NCT01577082View on ClinicalTrials.gov

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

542

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Asthma
Interventions
DRUG

CHF1535 200/6 µg

CHF 1535 (BDP/FF) 800/24 µg daily during 12 weeks

DRUG

BDP 100 µg

Beclomethasone Dipropionate 800µg daily during 12 weeks

Trial Locations (1)

56124

Cardio-Thoracic and Vascular Dept, University of Pisa, Pisa

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01577082 - Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients | Biotech Hunter | Biotech Hunter